Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1

Conditions

Myelodysplastic Syndromes 1Multiple Myeloma 1Leukemia 1Hematologic Diseases 1Graft vs Host Disease 1

Interventions

Lenalidomide 3Melphalan 2Granulocyte-Macrophage Colony-Stimulating Factor 2Dexamethasone 2Bortezomib 2sargramostim 1ixazomib 1fludarabine phosphate 1fludarabine 1Voriconazole 1Thalidomide 1Sugars 1Stem Cell Transplantation 1Platelet Transfusion 1Leukapheresis 1Fluconazole 1Cyclophosphamide 1Colony-Stimulating Factors 1Calcium Dobesilate 1Bone Marrow Transplantation 1Blood Specimen Collection 1B3(Fv)-PE38KDEL recombinant immunotoxin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Hematologic Diseases × Fluconazole × Clear all
NCT00023530 2016-02-18

Blood and Marrow Transplant Clinical Research Network

National Heart, Lung, and Blood Institute (NHLBI)

Phase NA Completed
MyeloidOther hematologic neoplasmPlasma cell

Graft vs Host Disease, Hematologic Diseases, Leukemia, Multiple Myeloma, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡